Chiara Astrua

832 total citations
22 papers, 322 citations indexed

About

Chiara Astrua is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, Chiara Astrua has authored 22 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Immunology and 8 papers in Dermatology. Recurrent topics in Chiara Astrua's work include Cutaneous Melanoma Detection and Management (8 papers), Immunotherapy and Immune Responses (7 papers) and Melanoma and MAPK Pathways (6 papers). Chiara Astrua is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Immunotherapy and Immune Responses (7 papers) and Melanoma and MAPK Pathways (6 papers). Chiara Astrua collaborates with scholars based in Italy, Belarus and Austria. Chiara Astrua's co-authors include Paolo Fava, Pietro Quaglino, Paola Savoia, Maria Teresa Fierro, Simone Ribero, Umberto Ricardi, Andrea Riccardo Filippi, Mauro Novelli, Martina Sanlorenzo and Simona Osella‐Abate and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Journal of Investigative Dermatology.

In The Last Decade

Chiara Astrua

19 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Astrua Italy 9 171 114 103 68 44 22 322
Fanélie Jouenne France 10 175 1.0× 197 1.7× 121 1.2× 46 0.7× 29 0.7× 39 421
Gabriela Turcu Romania 10 288 1.7× 117 1.0× 174 1.7× 38 0.6× 57 1.3× 26 463
Emily A. Merkel United States 11 244 1.4× 145 1.3× 53 0.5× 89 1.3× 49 1.1× 17 340
Aleksander Sekulic United States 8 221 1.3× 198 1.7× 46 0.4× 37 0.5× 42 1.0× 13 385
Sigrid M. C. Broekaert Germany 8 137 0.8× 133 1.2× 100 1.0× 87 1.3× 12 0.3× 11 338
Ruth Asher United Kingdom 9 163 1.0× 154 1.4× 207 2.0× 23 0.3× 26 0.6× 17 414
Elisabetta Broseghini Italy 11 135 0.8× 214 1.9× 64 0.6× 71 1.0× 149 3.4× 23 389
Giulia Veronesi Italy 11 186 1.1× 122 1.1× 49 0.5× 85 1.3× 39 0.9× 58 367
Kevin James Baker Ireland 6 121 0.7× 226 2.0× 153 1.5× 22 0.3× 29 0.7× 8 401
Burkhard Bueltmann Germany 6 252 1.5× 121 1.1× 74 0.7× 47 0.7× 33 0.8× 10 318

Countries citing papers authored by Chiara Astrua

Since Specialization
Citations

This map shows the geographic impact of Chiara Astrua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Astrua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Astrua more than expected).

Fields of papers citing papers by Chiara Astrua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Astrua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Astrua. The network helps show where Chiara Astrua may publish in the future.

Co-authorship network of co-authors of Chiara Astrua

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Astrua. A scholar is included among the top collaborators of Chiara Astrua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Astrua. Chiara Astrua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 51(1). 35–41.
2.
Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of guselkumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 50(8). 1590–1597. 1 indexed citations
3.
Mistrangelo, Massimiliano, Franco Picciotto, Pietro Quaglino, et al.. (2025). Feasibility and impact of sentinel lymph node biopsy in patients affected by ano-rectal melanoma. Techniques in Coloproctology. 29(1). 38–38.
4.
Roccuzzo, Gabriele, Egle Ramelyte, Chiara Astrua, et al.. (2024). Advances in the pharmacological management of cutaneous T-cell lymphoma. Expert Opinion on Pharmacotherapy. 25(7). 885–894. 1 indexed citations
5.
Roccuzzo, Gabriele, Chiara Astrua, Matteo Brizio, et al.. (2024). Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience. Journal of Clinical Medicine. 13(17). 5238–5238. 1 indexed citations
6.
Mastorino, Luca, Michela Ortoncelli, Chiara Astrua, et al.. (2024). Drug Survival and Clinical Course of Patients with Cancer Treated with Biologic Therapy for Psoriasis. Journal of Clinical Medicine. 13(21). 6546–6546. 4 indexed citations
7.
Roccuzzo, Gabriele, Paolo Fava, Chiara Astrua, et al.. (2024). Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma. Cancers. 16(17). 3095–3095. 3 indexed citations
8.
Quaglino, Pietro, Mauro Novelli, Paolo Fava, et al.. (2022). CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study. Disease Markers. 2022. 1–7. 4 indexed citations
9.
Quaglino, Pietro, Paolo Fava, Alessandro Pileri, et al.. (2020). Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome. Journal of Investigative Dermatology. 141(3). 484–495. 32 indexed citations
10.
Zocco, Davide, Simona Bernardi, Mauro Novelli, et al.. (2020). Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients. Scientific Reports. 10(1). 15745–15745. 57 indexed citations
11.
Pileri, Alessandro, Claudio Agostinelli, Maurizio Sessa, et al.. (2017). Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(5). 575–582. 18 indexed citations
12.
Fava, Paolo, Chiara Astrua, Martina Sanlorenzo, et al.. (2017). Treatment of metastatic melanoma: a multidisciplinary approach. Italian Journal of Dermatology and Venereology. 152(3). 241–261. 8 indexed citations
13.
Astrua, Chiara, Paolo Fava, Matteo Brizio, & Paola Savoia. (2017). A study of melanoma in Eastern European migrants in Italy. European Journal of Dermatology. 27(2). 139–143. 5 indexed citations
14.
Savoia, Paola, Chiara Astrua, & Paolo Fava. (2016). Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management. Human Vaccines & Immunotherapeutics. 12(5). 1092–1101. 48 indexed citations
15.
Fava, Paolo, Elena Marra, Chiara Astrua, et al.. (2016). Dermatological approach to vemurafenib skin toxicity: a single centre experience.. PubMed. 151(1). 25–31. 2 indexed citations
16.
Filippi, Andrea Riccardo, Paolo Fava, Serena Badellino, et al.. (2016). Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiotherapy and Oncology. 120(1). 1–12. 37 indexed citations
17.
Fava, Paolo, Massimiliano Bergallo, Chiara Astrua, et al.. (2015). Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas. Dermatology. 232(1). 38–43. 15 indexed citations
18.
Valpione, Sara, Chiara Martinoli, Paolo Fava, et al.. (2015). Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. European Journal of Cancer. 51(14). 2086–2094. 34 indexed citations
19.
Fava, Paolo, Chiara Astrua, Giovanni Cavaliere, et al.. (2014). Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. Journal of the European Academy of Dermatology and Venereology. 29(9). 1843–1845. 4 indexed citations
20.
Ribero, Simone, Simona Osella‐Abate, Martina Sanlorenzo, et al.. (2013). Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. British Journal of Dermatology. 169(6). 1240–1245. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanélie Jouenne Breakdown of academic impact, for papers by Gabriela Turcu Breakdown of academic impact, for papers by Emily A. Merkel Breakdown of academic impact, for papers by Aleksander Sekulic Breakdown of academic impact, for papers by Sigrid M. C. Broekaert Breakdown of academic impact, for papers by Ruth Asher Breakdown of academic impact, for papers by Elisabetta Broseghini Breakdown of academic impact, for papers by Giulia Veronesi Breakdown of academic impact, for papers by Kevin James Baker Breakdown of academic impact, for papers by Burkhard Bueltmann
Rankless by CCL
2026